🇺🇸 FDA
Pipeline program

Azilsartan medoxomil (TAK-491)

TAK-491_109

Phase 1 small_molecule terminated

Quick answer

Azilsartan medoxomil (TAK-491) for Hypertension is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hypertension
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials